Emicizumab 150mg/1ml solution for injection vials
NHS hospitals in England used £142,237,017 of indicative cost of Emicizumab 150mg/1ml solution for injection vials in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is up 15.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Emicizumab 150mg/1ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Emicizumab 150mg/1ml solution for injection vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £23,525,022 |
| Manchester University Nhs Ft | £21,472,017 |
| Leeds Teaching Hpls Nhs Trust | £15,530,379 |
| Sheffield Teaching Hospitals Nhs Trust | £11,219,069 |
| Univ Hpls Bristol Nhs Foundation Trust | £10,349,561 |
| Oxford University Hospitals Nhs Ft | £10,192,566 |
| Nottingham University Hospitals Trust | £9,178,140 |
| Barts Health Nhs Trust | £5,301,584 |
| East Kent Hospitals University Nhs Ft | £5,265,354 |
| Royal Free London Nhs Foundation Trust | £4,323,387 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.